Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Silk

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
The Journal of Experimental Medicine|September 20, 2006
Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseasesStephan D Gadola, Jonathan D Silk, Aruna Jeans, et al.
Gene Therapy|November 11, 2011
Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cellsK M Silk, J D Silk, N Ichiryu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cellsJonathan D Silk, Mariolina Salio, B Gopal Reddy, et al.
Cancer Research|September 22, 2016
Nutritional Stress Induced by Tryptophan-Degrading Enzymes Results in ATF4-Dependent Reprogramming of the Amino Acid Transporter Profile in Tumor CellsElina Timosenko, Hemza Ghadbane, Jonathan D Silk, et al.
The Journal of Clinical Investigation|December 16, 2004
Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapyJonathan D Silk, Ian F Hermans, Uzi Gileadi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
High avidity antigen-specific CTL identified by CD8-independent tetramer stainingEd Man-Lik Choi, Ji-Li Chen, Linda Wooldridge, et al.
Cell Reports Methods|August 5, 2025
MR1-ligand cross-linking identifies vitamin B6 metabolites as TCR-reactive antigensThierry Schmidlin, Enas Behiry, Hannah Thomas, et al.
The International Journal on Drug Policy|August 28, 2021
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage studyA Conway, H Valerio, A Peacock, et al.
HIV Medicine|July 14, 2017
Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) studyS L Pett, J Amin, A Horban, et al.
The Journal of Hospital Infection|December 5, 2003
Evidence-based guidelines for preventing healthcare-associated infections in primary and community care in EnglandC M Pellowe, R J Pratt, P Harper, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
The Journal of Experimental Medicine|September 20, 2006
Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseasesStephan D Gadola, Jonathan D Silk, Aruna Jeans, et al.
Gene Therapy|November 11, 2011
Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cellsK M Silk, J D Silk, N Ichiryu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cellsJonathan D Silk, Mariolina Salio, B Gopal Reddy, et al.
Cancer Research|September 22, 2016
Nutritional Stress Induced by Tryptophan-Degrading Enzymes Results in ATF4-Dependent Reprogramming of the Amino Acid Transporter Profile in Tumor CellsElina Timosenko, Hemza Ghadbane, Jonathan D Silk, et al.
The Journal of Clinical Investigation|December 16, 2004
Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapyJonathan D Silk, Ian F Hermans, Uzi Gileadi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
High avidity antigen-specific CTL identified by CD8-independent tetramer stainingEd Man-Lik Choi, Ji-Li Chen, Linda Wooldridge, et al.
Cell Reports Methods|August 5, 2025
MR1-ligand cross-linking identifies vitamin B6 metabolites as TCR-reactive antigensThierry Schmidlin, Enas Behiry, Hannah Thomas, et al.
The International Journal on Drug Policy|August 28, 2021
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage studyA Conway, H Valerio, A Peacock, et al.
HIV Medicine|July 14, 2017
Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) studyS L Pett, J Amin, A Horban, et al.
The Journal of Hospital Infection|December 5, 2003
Evidence-based guidelines for preventing healthcare-associated infections in primary and community care in EnglandC M Pellowe, R J Pratt, P Harper, et al.
Pageof 8